|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
B.Braun Pharmaceuticals
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name B.Braun Pharmaceuticals SA Previous name(s) Helvetica Profarm S.A. (2010) Headquarters 2, Louis Pasteur St.; TIMISOARA; Timis; 300264 |
Status: Non-Listed Legal Form: Public Limited Company Operational Status: Operational CUI: 09307999 Financial Auditors: S.C. A.B.A. AUDIT S.R.L. (2010) Total Employees: 110 Tel: 00 40-256-214.991;+40-256-214.993 |
|
Company Description |
|
S.C. Helvetica Profarm S.A. was founded in 1997 and became operational in 1999. The main field of activity is the production of solutions for perfusions under the licence of the B.Braun Concern, delivered exclusively by the Romanian company B.Braun Medical S.R.L. Note:In 2010 the company changed its name, Helvetica Profarm S.A. becoming B.Braun Pharmaceuicals S.A.. |
Company Analysis |
| According to the Individual - Non-Audited financial statement for the Year of 2010, total net operating revenues decreased with -17.44%, from RON 18,162,470 to RON 14,995,695 . Operating Results decreased from RON 533,939 to RON -2,686,598 . The results of the period reached RON -3,057,496 at the end of the period against RON 160,748 last year. Return on equity (Net income/Total equity) went from 1.34% to -34.39%, the Return On Asset (Net income / Total Asset) went from 0.90% to -10.98% and the Net Profit Margin (Net Income/Net Sales) went from 0.89% to -20.39% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 212.14% compared to 48.47% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.95 to 0.34 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 H1 (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Unit | 1 | 1 |
| ||
Balance Sheet
| ||
Total Assets |
33,206,740 |
27,841,897 |
| ||
Current Assets |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Total Liabilities |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Shareholders Equity |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Current Liabilities |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
| * All the accounts are in RON. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Operational Profit (Loss) |
X,XXX,XXX |
-X,XXX,XXX |
| ||
Net Profit (Loss) |
X,XXX,XXX |
-X,XXX,XXX |
| ||
| * All the accounts are in RON. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
-XX.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
-XX.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
-XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
-XX.XX% |
| ||
Return on Sales (ROS) |
XX.XX% |
-XX.XX% |
| ||
Return on Capital |
XX.XX% |
-XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.XX% |
| ||
Operating Profit Margin |
XX.XX% |
-XX.XX% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
X.XXx |
X.XXx |
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
X.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
X,XXX,XXX |
-X,XXX,XXX |
| ||
EBITDA |
X,XXX,XXX |
-X,XXX,XXX |
| ||
Bookvalue (BV) |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Net Cash |
-XX,XXX,XXX |
-XX,XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XX.XX% |
XX.XX% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Interest Coverage Ratio |
X.XX% |
-X.XX% |
| ||
Debt to equity |
XXX.XX% |
XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
 |